GoodRx Holdings (GDRX) Non-Current Debt (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Non-Current Debt data on file, last reported at $482.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 0.7% year-over-year to $482.4 million; the trailing twelve-month figure through Mar 2026 stood at $482.4 million (down 0.7% YoY), and the FY2025 full-year result was $483.3 million, down 0.71% from the prior year.
• Non-Current Debt steadied at $482.4 million in Q1 2026, from $483.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $654.8 million in Q1 2022 to a low of $482.4 million in Q1 2026.
• A 5-year average of $582.2 million and a median of $646.7 million in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt decreased 0.61% in 2022 and fell 24.89% in 2025, its largest moves.
• Tracing GDRX's Non-Current Debt over 5 years: stood at $651.8 million in 2022, then fell by 0.63% to $647.7 million in 2023, then fell by 24.86% to $486.7 million in 2024, then decreased by 0.71% to $483.3 million in 2025, then declined by 0.17% to $482.4 million in 2026.
• Business Quant data shows GDRX's Non-Current Debt at $482.4 million in Q1 2026, $483.3 million in Q4 2025, and $484.1 million in Q3 2025.